The U.S. Food and Drug Administration (FDA) has approved revumenib, a pioneering drug for relapsed or refractory acute ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Ziihera (zanidatamab-hrii), a novel therapy for ...

ONCOLife proudly presents an exclusive interview with Dr. Iris Kuss, VP and Global Development Lead Oncology at Bayer. In ...

Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. In this exclusive interview ...

Researchers from Cambridge University Hospitals, in collaboration with the NHS Health Research Authority, have launched the ...